New ventilator method may save fragile preemies from breathing tubes

NCT ID NCT06849596

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two ways to help extremely premature babies (born at 25-28 weeks) breathe right after birth. One method uses a standard manual T-piece device; the other uses a ventilator to deliver gentle puffs of air through a nasal mask. The goal is to see if the ventilator approach reduces the chance of death or serious complications like brain injury or chronic lung disease. About 780 babies will take part across multiple hospitals.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Ventilator-derived positive pressure ventilation (V-PPV) via nasal mask

What this could lead to

If it works, this could lead to a better way to help extremely premature babies breathe right after birth, reducing the need for a breathing tube and lowering the risk of death or brain injury.

What could go wrong

This is a relatively early-stage trial, and the ventilator method may not prove better than the standard T-piece. The babies are extremely fragile, so any breathing support carries risks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEONATAL RESUSCITATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

apnea of prematurity Lung Injury Premature Birth Respiratory Aspiration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • BC Children's and Women's Hospital

    NOT_YET_RECRUITING

    Vancouver, British Columbia, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • CHU Sainte Justine

    RECRUITING

    Montreal, Quebec, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Cedars-Sinai Guerin Children's

    RECRUITING

    Los Angeles, California, 90505, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Children's Hospital at London Health Sciences Centre

    NOT_YET_RECRUITING

    London, Ontario, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Foothills Medical Centre

    RECRUITING

    Calgary, Alberta, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • McMaster Children's Hospital

    RECRUITING

    Hamilton, Ontario, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Montreal Children's Hospital

    RECRUITING

    Montral, Quebec, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Mount Sinai Hospital

    RECRUITING

    Toronto, Ontario, M5G 1X5, Canada

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Rigshospitalet Coppenhagen

    NOT_YET_RECRUITING

    Copenhagen, Denmark

    Contact Email: •••••@•••••

    Contact

  • Royal Alexandra Hospital

    RECRUITING

    Edmonton, Alberta, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact